Top

Published in:

01-01-2019 | Letter to the Editor

Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder

Authors: Erlend Glasø Faltinsen, Ole Jakob Storebø, Christian Gluud

Published in: European Child & Adolescent Psychiatry | Issue 1/2019

Excerpt

We thank Padilha and colleagues for their network meta-analysis on efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents [1]. The network meta-analysis looks comprehensive and the results are interesting. We invite readers to consider the following potential limitations of the study. …

Padilha SCOS., Virtuoso S, Tonin FS, Borba HHL, Pontarolo R (2018). Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis. Eur Child Adolesc Psychiatry. https://doi.org/10.1007/s00787-018-1125-0 CrossRefPubMed

Storebø OJ, Ramstad E, Krogh HB, Nilausen TD, Skoog M, Holmskov M et al (2015) Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009885.pub2 (Art. No.: CD009885)CrossRefPubMed

Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y et al (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry 391(10128):1357–1366. https://doi.org/10.1016/S0140-6736(17)32802-7 CrossRef

Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17:1–12. https://doi.org/10.1016/0197-2456(95)00134-4 CrossRefPubMed

Higgins JPT, Altman DG, Sterne JAC (eds) (2017) Chapter 8: assessing risk of bias in included studies. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (eds) Cochrane handbook for systematic reviews of interventions version 5.2.0 [updated June 2017]. Cochrane. http://www.training.cochrane.org/handbook

Rodrigues-Tartari R, Swardfager W, Salum GA, Rohde LA, Cogo-Moreira H (2018) Assessing risk of bias in randomized controlled trials of methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Int J Methods Psychiatr Res 27:e1586. https://doi.org/10.1002/mpr.1586 CrossRef

Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L (2017) Industry sponsorship and research outcome. Cochrane Database of Syst Rev. https://doi.org/10.1002/14651858.MR000033.pub3 (Art. No.: MR000033)CrossRef

Punja S, Shamseer L, Hartling L, Urichuk L, Vandermeer B, Nikles J et al (2016) Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD009996.pub2 (Art. No.: CD009996)CrossRefPubMed

Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924–926. https://doi.org/10.1136/bmj.39489.470347.AD CrossRefPubMedPubMedCentral

10.

Catalá-López F, Hutton B, Núñez-Beltrán A, Page MJ, Ridao M, Macías Saint-Gerons D et al (2017) The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: a systematic review with network meta-analyses of randomised trials. PLoS One 12:e0180355. https://doi.org/10.1186/s13643-015-0005-7 CrossRefPubMedPubMedCentral

11.

Cipriani A, Higgins JPT, Geddes JR, Salanti G (2013) Conceptual and technical challenges in network meta-analysis. Ann Intern Med 159:130–137. https://doi.org/10.7326/0003-4819-159-2-201307160-00008 CrossRefPubMed

12.

InHout J, Ioannidis JPA, Rovers MM, Goerman JJ (2016) Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open 6:e010247. https://doi.org/10.1136/bmjopen-2015-010247 CrossRef

13.

Faltinsen EG, Storebø O, Jakobsen J, Boesen K, Lange T, Gluud C (2018) Network meta-analysis: the highest level of medical evidence? BMJ Evid Based Med 23:56–59. https://doi.org/10.1136/bmjebm-2017-110887 CrossRefPubMed

14.

Del Re AC, Spielmans GI, Flückiger C, Wampold BE (2013) Efficacy of new generation antidepressants: differences seem illusory. PLoS One 8:e63509. https://doi.org/10.1371/journal.pone.0063509 CrossRefPubMedPubMedCentral

Title: Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder
Authors: Erlend Glasø Faltinsen
Ole Jakob Storebø
Christian Gluud
Publication date: 01-01-2019
Publisher: Springer Berlin Heidelberg
Published in: European Child & Adolescent Psychiatry / Issue 1/2019
Print ISSN: 1018-8827
Electronic ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-018-1164-6

ACC 2024 Congress

Springer Medicine

Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder

Excerpt

ACC 2024 Congress

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2019

Population attributable risk of factors associated with the repetition of self-harm behaviour in young people presenting to clinical services: a systematic review and meta-analysis

Prevalence of DSM-5 anxiety disorders, comorbidity, and persistence of symptoms in Spanish early adolescents

Maternal breastfeeding and attention-deficit/hyperactivity disorder in children: a meta-analysis

Do autism spectrum disorder and anorexia nervosa have some eating disturbances in common?

Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome

A prospective cohort study of biopsychosocial factors associated with childhood urinary incontinence